| Identification | |
| Name: | 5-Pyrimidinecarboxamide,4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)- |
| Synonyms: | (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine;Avanafil;TA 1790; |
| CAS: | 330784-47-9 |
| Molecular Formula: | C23H26 Cl N7 O3 |
| Molecular Weight: | 483.95 |
| InChI: | InChI=1/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.372g/cm3 |
| Refractive index: | 1.651 |
| Appearance: | White solid |
| Safety Data | |
 |
|
